These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7267677)

  • 1. Double-blind assessment of the activity of minaprine (30038-CB) in child psychiatry.
    Maffla AG
    Pharmatherapeutica; 1981; 2(9):601-6. PubMed ID: 7267677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
    Bohacek N; Ravic M; Bizière K
    Drugs Exp Clin Res; 1987; 13(7):435-42. PubMed ID: 3308390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Open study of minaprine in a child psychiatry population (author's transl)].
    de Villard R; Dallery J; Maillet J; Soulier C
    Neuropsychiatr Enfance Adolesc; 1981; 29(4-5):255-8. PubMed ID: 7335167
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimentation with minaprine in child psychiatry].
    Marcelli D; Braconnier A; Duché DJ
    Neuropsychiatr Enfance Adolesc; 1980; 28(7-8):349-51. PubMed ID: 6106166
    [No Abstract]   [Full Text] [Related]  

  • 5. Multicentric double-blind study comparing efficacy and safety of minaprine and imipramine in dysthymic disorders.
    Salzmann E; Robin JL
    Neuropsychobiology; 1995; 31(2):68-75. PubMed ID: 7760988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
    Isaac MT; Isaac MB; Gallo F; Tournoux A
    Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Randomized double-blind comparative study of minaprine (200mg/j) and of placebo on memory loss].
    Allain H; Belliard S; Lieury A; Menard G; Patat A; Le Coz F; Gandon JM
    Therapie; 1996; 51(2):155-62. PubMed ID: 8763050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Minaprine].
    Rubio A; Azanza JR; Cuena R; Honorato J
    Rev Med Univ Navarra; 1984 Dec; 28(4):47-8. PubMed ID: 6098950
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
    Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA
    Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
    Amsterdam JD; Bodkin JA
    J Clin Psychopharmacol; 2006 Dec; 26(6):579-86. PubMed ID: 17110814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.
    Levitan RD; Shen JH; Jindal R; Driver HS; Kennedy SH; Shapiro CM
    J Psychiatry Neurosci; 2000 Sep; 25(4):337-46. PubMed ID: 11022398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Minaprine and stammering].
    Yana M
    Agressologie; 1981; 22(2):83. PubMed ID: 7270799
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
    Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF
    J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
    Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P
    J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Niaprazine in behavior disorders in children. Double-blind comparison with placebo].
    Franzoni E; Masoni P; Mambelli M; Marzano P; Donati C
    Pediatr Med Chir; 1987; 9(2):185-7. PubMed ID: 2958783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.